We recommend using albumin infusions based on clinical indicators of hypovolaemia (including oliguria, acute kidney injury, prolonged capillary refill time, tachycardia, hypotension and abdominal discomfort) or upon failure to thrive. This evidence concerns the gene ALB and Failure to thrive.